THE EFFECTS OF IMMUNE STATUS AND RACE ON HEALTH-SERVICE USE AMONG PEOPLE WITH HIV DISEASE

被引:55
作者
PIETTE, JD
MOR, V
MAYER, K
ZIERLER, S
WACHTEL, T
机构
[1] BROWN UNIV,DEPT MED,PROVIDENCE,RI 02912
[2] DEPT COMMUNITY HLTH,PROVIDENCE,RI
[3] BROWN UNIV,AIDS PROGRAM,PROVIDENCE,RI 02912
[4] BROWN UNIV,BROWNS CTR GERONTOL & HLTH CARE RES,PROVIDENCE,RI 02912
关键词
D O I
10.2105/AJPH.83.4.510
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. The purpose of this study was to examine the relationship between CD4 lymphocyte count and health service use, and to determine whether differences in the rates of service use between Whites and people of color could be identified. Methods. Medical records for 571 HIV-infected individuals were analyzed. Incidence rates and relative rates across CD4 strata (defined by cell counts) were calculated for inpatient and outpatient events. Rate ratios comparing people of color with Whites were estimated within strata, adjusting for confounding factors using a Mantel-Haenszel pooling procedure. Results. Both inpatient and outpatient service use increased over progressively lower levels of CD4 counts. Within each CD4 stratum and controlling for other factors, White participants had more HIV clinic visits and fewer admissions than people of color. Among participants with fewer than 51 CD4 cells per cubic millimeter, people of color were admitted 20% more often, had 35% more inpatient days per person-year, and had only 74% as many HIV clinic visits as their White counterparts. Conclusions. These results indicate that CD4 lymphocyte count is strongly associated with increased usage of health services. People of color with HIV disease are more likely than similar Whites to be admitted to the hospital and less likely to use outpatient care.
引用
收藏
页码:510 / 514
页数:5
相关论文
共 33 条
  • [1] CONTRASTS IN SURVIVAL OF BLACK AND WHITE CANCER-PATIENTS, 1960-73
    AXTELL, LM
    MYERS, MH
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (06): : 1209 - 1215
  • [2] Berenson GS, 1989, CLIN CARDIOL S4, V12, p[IV, 3]
  • [3] ACCESS TO MEDICAL-CARE FOR BLACK AND WHITE AMERICANS - A MATTER OF CONTINUING CONCERN
    BLENDON, RJ
    AIKEN, LH
    FREEMAN, HE
    COREY, CR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (02): : 278 - 281
  • [4] ONCE-DAILY ADMINISTRATION OF 2',3'-DIDEOXYINOSINE (DDI) IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME OR AIDS-RELATED COMPLEX - RESULTS OF A PHASE-I TRIAL
    COOLEY, TP
    KUNCHES, LM
    SAUNDERS, CA
    RITTER, JK
    PERKINS, CJ
    MCLAREN, C
    MCCAFFREY, RP
    LIEBMAN, HA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (19) : 1340 - 1345
  • [5] Cooper R S, 1991, Cardiovasc Clin, V21, P205
  • [6] CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
  • [7] TRENDS IN CIGARETTE-SMOKING IN THE UNITED-STATES - THE CHANGING INFLUENCE OF GENDER AND RACE
    FIORE, MC
    NOVOTNY, TE
    PIERCE, JP
    HATZIANDREU, EJ
    PATEL, KM
    DAVIS, RM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (01): : 49 - 55
  • [8] SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS
    FISCHL, MA
    DICKINSON, GM
    LAVOIE, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08): : 1185 - 1189
  • [9] FISCHL MA, 1987, NEW ENGL J MED, V317, P155
  • [10] FLEISHMAN J, IN PRESS EVALUATION